United StatesJ&J Subsidiary Proposes Paying About USD 6.48B Over 25 years To Settle Talc LawsuitsBY Associated Press
NationalExplained: Why Maharashtra Stopped Johnson & Johnson Baby Powder's Sale, HC Ruling And Other ControversiesBY Outlook Web Desk
NationalBombay HC Allows Johnson & Johnson To Continue Manufacturing Baby Powder But Disallows Sale Till Further OrdersBY PTI
NationalExplained: Johnson & Johnson To Stop Selling Talc Baby Powder, The Talc Controversy, And Alleged Talc-Cancer LinkBY Madhur Sharma
Making A DifferenceCovid-19 Vaccines: US CDC Panel Recommends Pfizer, Moderna Over J&J ShotBY Outlook Web Desk
NationalCovaxin Gets WHO Nod For Emergency Use: What That Means For Indian TravelersBY Outlook Web Desk
Making A DifferenceUS May Recommend Boosters Eight Months After Second Covid Vaccine DoseBY Associated Press
NationalJohnson & Johnson Hopeful About Getting EUA Of It's Single-Dose COVID Vaccine In IndiaBY Outlook Web Desk
Making A Difference'Not One Dose... ': Africa's Covid-19 Envoy Blasts EU, COVAX Over Vaccine CrisisBY Associated Press
Making A DifferenceDespite Evidence Of Rare Blood Clot Risk, US To Resume Use Of J&J’s Covid-19 VaccineBY Associated Press
NationalRemdesivir An 'Investigational Drug', Not Suitable For Home Use: Niti AayogBY Outlook Web Bureau
Making A DifferenceUS: Johnson & Johnson Begins Testing Covid-19 Vaccines On TeenagersBY Associated Press
Making A DifferenceJ&J To Pay Rs 890 Cr To Woman Who Alleged Company’s Talcum Powder Contains Cancerous AgentsBY Outlook Web Bureau
.jpg?auto=format%2Ccompress&fit=max&format=webp&w=300&dpr=1.0)
_571_855.png?auto=format%2Ccompress&fit=max&format=webp&w=300&dpr=1.0)
.jpg?auto=format%2Ccompress&fit=max&format=webp&w=300&dpr=1.0)
.jpg?auto=format%2Ccompress&fit=max&format=webp&w=300&dpr=1.0)
.jpg?auto=format%2Ccompress&fit=max&format=webp&w=300&dpr=1.0)
